193 related articles for article (PubMed ID: 35585570)
21. Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.
Zhang Y; Gao Z; Zhang X; Yuan Z; Ma T; Li G; Gao X
Exp Ther Med; 2021 Apr; 21(4):332. PubMed ID: 33732305
[TBL] [Abstract][Full Text] [Related]
22. Intraocular tumour necrosis factor ligand related molecule 1 A links disease progression of proliferative diabetic retinopathy after primary vitrectomy.
Wang T; Li J; Xie R; Wang J; Zhang W; Jiang F; Du M; Wang X; Huang B; Brant R; Zhang C; Yan H
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):966-976. PubMed ID: 32064668
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685
[No Abstract] [Full Text] [Related]
24. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.
Funatsu H; Yamashita H; Noma H; Mimura T; Nakamura S; Sakata K; Hori S
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):3-8. PubMed ID: 15258777
[TBL] [Abstract][Full Text] [Related]
25. Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma.
Nakamura K; Kojima S; Inoue-Mochita M; Tanihara H; Inoue T
Exp Eye Res; 2022 Oct; 223():109204. PubMed ID: 35921964
[TBL] [Abstract][Full Text] [Related]
26. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3874-9. PubMed ID: 23674760
[TBL] [Abstract][Full Text] [Related]
27. Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma.
Guo X; Wang Y; Yang L; Wang P; Chen K; Zhou L; Wu Y
Int Ophthalmol; 2021 Aug; 41(8):2869-2877. PubMed ID: 33895882
[TBL] [Abstract][Full Text] [Related]
28. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
[TBL] [Abstract][Full Text] [Related]
29. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy.
Wang W; Qu C; Yan H
Front Endocrinol (Lausanne); 2023; 14():1098165. PubMed ID: 36896181
[TBL] [Abstract][Full Text] [Related]
30. Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.
Hu Z; Cao X; Chen L; Su Y; Ji J; Yuan S; Fransisca S; Mugisha A; Zou W; Xie P; Liu Q
Acta Ophthalmol; 2022 May; 100(3):e726-e736. PubMed ID: 34260829
[TBL] [Abstract][Full Text] [Related]
31. Aqueous Humor Analyses in Patients with Diabetic Retinopathy Who Had Undergone Panretinal Photocoagulation.
Kwon JW; Oh J
J Diabetes Res; 2022; 2022():1897344. PubMed ID: 35770197
[TBL] [Abstract][Full Text] [Related]
32. Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after conbercept treatment.
Wang T; Chen H; Du X; Li N; Chen Y; Min H
J Proteomics; 2023 Mar; 276():104838. PubMed ID: 36764651
[TBL] [Abstract][Full Text] [Related]
33. Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents.
Chen H; Qiu B; Gao G; Chen Y; Min H; Wu Z
Exp Eye Res; 2022 Mar; 216():108942. PubMed ID: 35032522
[TBL] [Abstract][Full Text] [Related]
34. Increased interleukin-6 in aqueous humor of neovascular glaucoma.
Chen KH; Wu CC; Roy S; Lee SM; Liu JH
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2627-32. PubMed ID: 10509659
[TBL] [Abstract][Full Text] [Related]
35. The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy.
Sun D; Lin Y; Zeng R; Yang Z; Deng X; Lan Y
Eur J Ophthalmol; 2021 Nov; 31(6):3057-3067. PubMed ID: 33334171
[TBL] [Abstract][Full Text] [Related]
36. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
[TBL] [Abstract][Full Text] [Related]
37. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
38. [The change of the level of the vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma before and after anterior retinal cryotherapy].
Chen T; Zeng SQ; Lu YY; Huang LY; Dai H
Zhonghua Yan Ke Za Zhi; 2007 Jul; 43(7):622-5. PubMed ID: 17897552
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy.
Yang Z; Di Y; Ye J; Yu W; Guo Z
Front Endocrinol (Lausanne); 2023; 14():1171628. PubMed ID: 37305048
[TBL] [Abstract][Full Text] [Related]
40. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.
Tripathi RC; Li J; Tripathi BJ; Chalam KV; Adamis AP
Ophthalmology; 1998 Feb; 105(2):232-7. PubMed ID: 9479280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
